Home » Topics » Disease categories and therapies » Dental

Dental
RSS

ActoGeniX reports on phase I AG-013 trial

Aug. 23, 2012

IND cleared for phase I study of peptide to prevent dental caries

May 30, 2012

FDA approves first cell-based product made from allogeneic human cells and bovine collagen

March 14, 2012

Promising nanoparticle-based dental treatment developed in Germany

Jan. 25, 2012

BioMimetic obtains CE mark for growth factor-enhanced matrix

Jan. 4, 2012

Acacia Pharma initiates phase II study of locally administered xerostomia drug

July 25, 2011

PMX-30063 shows activity against oral mucositis in animal study

May 24, 2011

Septodont acquires local anesthesia reversal agent OraVerse from Novalar

March 21, 2011

Acacia Pharma completes phase I APD-515 trial for xerostomia in advanced cancer

Feb. 16, 2011

Oragenics plans second phase I trial of SMaRT replacement therapy

Feb. 2, 2011